← Open Payments lookup

AMINA OSMAN: Open Payments

NPI 1952725152 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$632 in 24 payments from 7 companies in 2025. Trend: 2023 $72 · 2024 $184 · 2025 $632

Food & beverage: $632
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.4$194
E.R. Squibb & Sons, L.L.C.5$114
Alkermes, Inc.6$108
Neurocrine BioSciences, Inc.3$75
Otsuka America Pharmaceutical, Inc.3$63
ABBVIE INC.2$43
Janssen Pharmaceuticals, Inc1$34

Products named: UZEDY, COBENFY, ARISTADA, INGREZZA, REXULTI, VRAYLAR, INVEGA SUSTENNA.

Industry payments across DC — which companies pay providers there.